What is the GHS hazard classification for Oxalic acid?
Oxalic acid (CAS 144-62-7) is classified under EU CLP Annex VI as Acute Tox. 4 *; Acute Tox. 4 * with signal word Warning. Hazard statements: H312; H302. Source: EU CLP Annex VI (ECHA).
Also known as: Ethanedioic acid, Aktisal, Aquisal, DeerClean, NSC 132055 (+15 more)
CAS 144-62-7
Oxalic acid (CAS 144-62-7) is a chemical substance with GHS signal word Warning; key hazard signal: H312; H302. Key regulatory status: REACH registered, 14 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from ECHA CLP, EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH, ILO ICSC, OSHA.
CAS, identifiers, formula, and alternate names for the matched substance record.
EU harmonized hazard classification, hazard statements, pictograms, and signal word.
| Hazard Class | H-Statements | Pictograms | Signal |
|---|---|---|---|
| Acute Tox. 4 *; Acute Tox. 4 * | H312; H302 | GHS07 | Warning |
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| GHS Signal Word | DANGER |
| GHS Hazard Statements | Harmful if swallowed Causes severe skin burns and eye damage May cause respiratory irritation |
| Short-term Effects | The substance is corrosive to the eyes, skin and respiratory tract. Corrosive on ingestion. The substance may cause effects on the calcium balance after ingestion. Exposure at high levels could cause death. |
| Long-term Effects | Repeated or prolonged contact with skin may cause dermatitis. Exposure may result in kidney stones, slow-healing ulcers and black finger nails. |
| Routes of Exposure | The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. Serious local effects by all routes of exposure. |
Occupational exposure limits from OSHA, NIOSH, and ACGIH rows.
| Agency | Metric | Value | ppm | mg/m3 | Skin |
|---|---|---|---|---|---|
| OSHA | TWA | 1 mg/m³ | - | 1 | N |
| NIOSH | TWA | 1 mg/m³ | - | 1 | N |
| NIOSH | STEL | 2 mg/m³ | - | 2 | N |
| ACGIH | TWA | 1 mg/m³ [2014] | - | 1 | N |
| ACGIH | STEL | 2 mg/m³ [2014] | - | 2 | N |
| CAL/OSHA | TWA | 1 mg/m³ | - | 1 | N |
| CAL/OSHA | STEL | 2 mg/m³ | - | 2 | N |
| NIOSH | IDLH | 500 mg/m³ | - | 500 | - |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| pharmaceutical | US International Trade Commission | CPCat |
| drinking_water; Europe; manufacturing; plastic_additive | Belgaqua | CPCat |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| active_ingredient; Europe; Pesticides | Commission of the European Communities | CPCat |
| active_ingredient; animal_products; Europe; pharmaceutical; residue | EU | CPCat |
| Cleaning products and household care; Europe | Danish Environmental Protection Agency | Danish EPA |
| Cleaning products and household care - laundry and fabric treatment - laundry stain remover; detected; Europe | Danish Environmental Protection Agency | Danish EPA |
| Cleaning products and household care - laundry and fabric treatment - laundry stain remover; detected; Europe | Danish Environmental Protection Agency | Danish EPA |
| Cleaning products and household care - laundry and fabric treatment - laundry stain remover; Europe | Danish Environmental Protection Agency | Danish EPA |
| Europe; Specialty occupational products | Danish Environmental Protection Agency | Danish EPA |
| Canada; pharmaceutical | DrugBank | DrugBank |
| Europe; Personal care; restricted | European Commission | CosIng |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 25.7483810718647 | uM | AC50 | - | - | NTP_ICE_endocrine |
| 18.5653394227728 | uM | ACC | - | - | NTP_ICE_endocrine |
| 310.33 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| >630.238 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 1000 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| =3.11 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 0.9 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| -0.9 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| - | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 0.45 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 717.2 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 0.000011 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 0.000011 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 0.000011 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 0.000011 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 6.3 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 15 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 15 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 15 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 15 | % | EC3 | Dermal | Mouse | NTP_ICE_skin_sensitization |
| 9E7R5L6H31 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9E7R5L6H31 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9E7R5L6H31 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9E7R5L6H31 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| >2000 | uM | IC50 | Dermal | - | NTP_ICE_skin_sensitization |
| 2.7 | ratio | Imax | Dermal | - | NTP_ICE_skin_sensitization |
| =7500 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =1900 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| ~5000 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =1.88 | mg/mL | LOEL | oral | Mouse | ToxValDB_ECOTOX |
| =2.5 | % | LOEL | oral | Rat | ToxValDB_ECOTOX |
| =5 | % | LOEL | oral | Rat | ToxValDB_ECOTOX |
| =8 | % | LOEL | oral | Rat | ToxValDB_ECOTOX |
| =80.6 | mg/L | LOEL | oral | Mouse | ToxValDB_ECOTOX |
| =340 | mg/kg bw/day | LOEL | oral | Mouse | ToxValDB_ECHA_IUCLID |
| =450 | mg/kg bw/day | LOEL | oral | Mouse | ToxValDB_ECHA_IUCLID |
| =1780 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =1980 | mg/kg bw/day | LOEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
| 0.00766 | unitless | Model Score | - | - | NTP_ICE_endocrine |
| 0.0225 | unitless | Model Score | - | - | NTP_ICE_endocrine |
| =162 | mg/kg bw/day | NOAEL | oral | Mouse | ToxValDB_ECHA_IUCLID |
| <=1000 | ppm | NOAEL | oral | Mouse | ToxValDB_ECHA_IUCLID |
| ~2000 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =0.2 | % | NOEL | oral | Mouse | ToxValDB_ECOTOX |
| =0.9 | mg/mL | NOEL | oral | Mouse | ToxValDB_ECOTOX |
Showing 49 of 49 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Oxalic acid | 205-634-3 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Oxalic acid (CAS 144-62-7) is classified under EU CLP Annex VI as Acute Tox. 4 *; Acute Tox. 4 * with signal word Warning. Hazard statements: H312; H302. Source: EU CLP Annex VI (ECHA).
Oxalic acid has 49 NOAEL studies in the database. The lowest reported value is -0.9 % via Dermal. Source: NTP_ICE_skin_sensitization.
Oxalic acid appears on 13 regulatory/inventory lists including IFRA Transparency, pharmaceutical, drinking_water; Europe; manufacturing; plastic_additive, and 10 more. Source: EPA CPDat.
Occupational exposure limits for Oxalic acid are set by OSHA, NIOSH, ACGIH. 8 limit values from official agencies are documented in the database. Source: OSHA, NIOSH, ACGIH.
Yes, Oxalic acid is also indexed as a cosmetic ingredient under the name OXALIC ACID. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from ECHA CLP Annex VI, EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, ILO/WHO ICSC, OSHA/NIOSH/ACGIH, CosIng / Ingredients DB, ChEMBL / DailyMed, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Oxalic acid also appears in cosmetics, pharmaceutical, cannabis databases.